Billing and Coding: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer

This billing/coding guidance specifies how to report the MolDX Inivata/InVisionFirst® lung liquid biopsy (InvisionFirst®–Lung) under LCD L37921. Submit CPT 81479 with 1 unit of service, include the appropriate DEX Z‑Code identifier adjacent to the CPT code in the specified electronic or paper claim fields (Loop 2400/SV101-7 or Box 19 for Part B; SV202-7 or Block 80 for Part A), and report the relevant ICD-10-CM diagnosis code for lung cancer. Coverage specifics and clinical eligibility are determined by the referenced LCD L37921.

"InvisionFirst®–Lung liquid biopsy for patients with lung cancer as covered per MolDX Local Coverage Determination L37921."

Sign up to see full coverage criteria, indications, and limitations.